105973-37-3

Usage

Uses

Used in Chemical Synthesis:
2-(cyclohexyloxy)aniline is used as an intermediate in the chemical synthesis for its ability to contribute to the formation of a wide range of organic compounds. Its unique structure allows it to be a building block in the production of dyes, pharmaceuticals, and polymers, enhancing the diversity of commercial products.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 2-(cyclohexyloxy)aniline is used as a key component in the development of new drugs. Its chemical properties enable it to be incorporated into medicinal compounds, potentially leading to the creation of novel therapeutic agents.
Used in Dye Manufacturing:
2-(cyclohexyloxy)aniline is utilized as a precursor in the manufacturing of dyes due to its reactive nature and ability to form colored compounds, which are essential for various applications in textiles, inks, and other industries.
Used in Polymer Production:
In the polymer industry, 2-(cyclohexyloxy)aniline is used as a monomer or a component in the synthesis of polymers. Its incorporation can influence the polymer's properties, such as stability, color, and other characteristics, making it suitable for specific applications.
It is crucial to handle 2-(cyclohexyloxy)aniline with care due to its potential hazards if not properly managed, ensuring safety in its applications across different industries.

Upstream product

• 108-93-0 cyclohexanol 
• 1493-27-2 ortho-nitrofluorobenzene 
• 30718-74-2 2-cyclohexyloxynitrobenzene 

Downstream Products

• 101450-31-1 N_.N-Bis-(2-hydroxyaethyl)-2-cyclohexyloxy-anilin 
• 1323064-60-3 C₄₅H₃₅NO₄ 
• 627098-50-4 2-cyclohexyloxy-N-cyclohexylaniline 

Relevant academic research and scientific papers

A molecular balance for measuring aliphatic CH-π interactions

A series of conformationally flexible bicyclic N-arylimides were employed as molecular balances to study the weak aliphatic CH-π interaction between alkyl and arene groups. The formation of intramolecular CH-π interactions in the folded conformers was characterized by X-ray crystallography. The strengths of the interactions were characterized in CDCl3 by the changes in the folded/unfolded ratios, as measured by 1H NMR. The CH-π interaction between a methyl group and an aromatic surface was ～1.0 kcal/mol and was easily disrupted or masked by conformational entropy and repulsive steric interactions.

NOVEL USE OF THIENOPYRIMIDINES

The present invention relates to the use of thienopyrimidine compounds for the production of pharmaceutical compositions for the treatment of inflammatory diseases.

THIENOPYRIMIDINES FOR PHARMACEUTICAL COMPOSITIONS

The present invention relates to novel pharmaceutical compositions of general formula (I) comprising thienopyrimidine compounds. Moreover, the present invention relates to the use of the thienopyrimidine compounds of the invention for the production of pharmaceutical compositions for the prophylaxis and/or treatment of diseases which can be influenced by the inhibition of the kinase activity of Mnk1 and/or Mnk2 (Mnk2a or Mnk2b) and/or variants thereof.

Synthesis and structure of four-coordinate dimethyl aluminium complexes incorporating new N,O-chelating arylamido ligands

A new type of arylamido ligands with an intramolecular coordinating ortho -ether-substituent (i.e. a O,N- chelating ligand) is introduced. The achiral and chiral 4-coordinate dimethyl aluminium complexes [2-ROC6H4NR′] AlMe

Derivatives of benzosulphonamides as inhibitors of the enzyme cyclooxygenase II

Compounds of the formula (I) in which A is oxygen, sulphur or NH; B is a group of the formula (IIa) or (IIb); and the other variables have the meaning given in claim 1, may be used as inhibitors of the enzyme cyclooxygenase II STR1

Sulfonanilide compounds

Sulfonanilide compounds represented by the formula STR1 wherein R1 is a lower alkyl group or a trifluoromethyl group, R2 is a cycloalkylidenemethyl group, a group of the formula --A--R3 (wherein A is an oxygen atom, a sulf